Deltasone and Uveitis - a phase IV clinical study of FDA data

Summary:

Uveitis is reported as a side effect among people who take Deltasone (prednisone), especially for people who are female, 20-29 old, have been taking the drug for < 1 month also take Solu-Medrol, and have Malignant melanoma.

The phase IV clinical study analyzes which people have Uveitis when taking Deltasone. It is created by eHealthMe based on reports of 4,137 people who have side effects when taking Deltasone from the FDA, and is updated regularly.

What is Deltasone?

Deltasone has active ingredients of prednisone. eHealthMe is studying from 4,243 Deltasone users. Check the latest studies of Deltasone.

What is Uveitis?

Uveitis (inflammation of the uvea) is found to be associated with 830 drugs and 1,532 conditions by eHealthMe. Check the latest studies of Uveitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 08, 2026

4,137 people reported to have side effects when taking Deltasone.
Among them, 11 people (0.27%) have Uveitis.

Among these 11 people:

How long have people been on Deltasone when they have Uveitis? *

What is the gender of people who have Uveitis when taking Deltasone? *

female: 80 %
male: 20 %

What is the age of people who have Uveitis when taking Deltasone? *

What are other drugs people take besides Deltasone? *

What are other side effects people have besides Uveitis? *

Retinal Detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue): 4 people, 36.36%
Blindness: 3 people, 27.27%
Diabetes: 3 people, 27.27%
Pain: 2 people, 18.18%
Joint Pain: 2 people, 18.18%
Depression: 1 person, 9.09%
Headache (pain in head): 1 person, 9.09%
Granuloma (a small area of inflammation due to tissue injury): 1 person, 9.09%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 9.09%
Fever: 1 person, 9.09%

What are the existing conditions these people have? *

Malignant Melanoma (skin cancer rises from melancytes): 4 people, 36.36%
Iridocyclitis (inflammation of the iris and ciliary body of the eye): 3 people, 27.27%
Diabetes Insipidus (diabetes caused by a deficiency of the pituitary hormone vasopressin, which regulates kidney function): 3 people, 27.27%
Cyclitis (inflammation of the ciliary body (eye)): 3 people, 27.27%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 9.09%
Pain: 1 person, 9.09%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 1 person, 9.09%
Chronic Myelomonocytic Leukaemia (cancers of the blood-forming cells of the bone marrow): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Deltasone and have Uveitis?

- Check whether Uveitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Deltasone:

Deltasone (4,243 reports)

Uveitis treatments and more:

Uveitis (29,545 reports)

Browse all side effects of Deltasone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Uveitis:

Uveitis (830 drugs)

Browse all the conditions that are associated with Uveitis:

Uveitis (1,532 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on prednisone (the active ingredients of Deltasone) and Deltasone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.